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Renal fibrosis is characterized by progressive accumulation of extracellular matrix (ECM)
proteins, resulting in loss of organ function and eventually requiring renal replacement
therapy. Unfortunately, no efficacious treatment options are available to halt renal fibrosis
and translational models to test pharmacological agents are not always representative.
Here, we evaluated murine precision-cut kidney slices (mPCKS) as a promising ex vivo
model of renal fibrosis in which pathophysiology as well as therapeutics can be studied.
Unique to this model is the use of rodent as well as human renal tissue, further closing the
gap between animal models and clinical trials. Kidneys from C57BL/6 mice were used
to prepare mPCKS and slices were incubated up to 96h. Viability, morphology, gene
expression of fibrosis markers (Col1a1, Acta2, Serpinh1, Fn1, and Pai-1), inflammatory
markers (Il1b, Il6, Cxcl1), and protein expression (collagen type 1, α-smooth muscle
actin, HSP47) were determined. Furthermore, to understand the role of the transforming-
growth factor β (TGF-β) pathway in mPCKS, slices were incubated with a TGF-β receptor
inhibitor (LY2109761) for 48 h. Firstly, viability and morphology revealed an optimal
incubation period of 48 h. Secondly, we demonstrated an early inflammatory response
in mPCKS, which was accompanied by subsequent spontaneous fibrogenesis. Finally,
LY2109761 showed great antifibrotic capacity in mPCKS by decreasing fibrosis markers
on mRNA level as well as by reducing HSP47 protein expression. To conclude, we here
present an ex vivo model of renal fibrosis, which can be used to further unravel the
mechanisms of renal fibrogenesis and to screen antifibrotic therapy efficacy.
Keywords: precision-cut kidney slices, ex vivo model, renal fibrosis, transforming-growth factor β, antifibrotic
therapies, chronic kidney diseases
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INTRODUCTION
Renal fibrosis is an integral part of the pathophysiological
mechanism underlying the development and progression of
chronic kidney disease (CKD), and is regarded as the most
damaging process responsible for renal function decline
(Schanstra et al., 2015). CKD affects about 10% of the population
and substantially impacts health care budgets. Moreover, the
global incidence of CKD is continuously rising (Couser et al.,
2011; Jha et al., 2013). CKD is irreversible and can progress to
end-stage renal disease, ESRD, (estimated glomerular filtration
rate < 15 ml/min/1.78 m2) whereby renal replacement therapy
such as dialysis or renal transplantation is needed.
Renal fibrosis is the consequence of an imbalanced
extracellular matrix (ECM) turnover caused by continuous
noxious stimuli such as trauma, infection, ischemia, or a
systemic disease (Declèves and Sharma, 2014; Mutsaers et al.,
2015). A multitude of complex pathways are implicated in
the pathogenesis of renal fibrosis of which the transforming
growth factor (TGF)-β pathway is regarded as the master
regulator (Eddy and Fogo, 2006; Meng et al., 2016). Binding
of TGF-β to a serine-threonine kinase type II receptor results
in the recruitment and phosphorylation of a type I receptor,
which in turn phosphorylates SMADs thereby initiating a
host of signaling cascades (Massagué, 2012; Rockey et al.,
2015). TGF-β is synthesized and secreted by inflammatory
cells and a variety of effector cells. Activation of the pathway
results in the formation and deposition of ECM proteins,
mainly by activated interstitial (myo)fibroblasts (Rockey et al.,
2015).
A myriad of experimental treatment modalities for renal
fibrosis have been developed in hopes of retarding or even
reversing fibrogenesis (Lee et al., 2015). Although several studies
have been successful at the pre-clinical level, only limited
advances have been made in the translation of these findings
to the level of patient treatment. One of the limiting factors
during the drug development process is the translation from
in vitro/vivo models to the clinic. While in vitro models lack
cellular heterogeneity, animal experiments do not fully reflect
the human situation and results differ per strain (Inoue et al.,
2015). To achieve a greater understanding of renal fibrosis and
thus accelerate the discovery of effective therapeutic targets,
there is an urgent need for adequate translational models.
To this end, precision-cut kidney slices (PCKS) have been
developed as disease model using either murine or human
renal tissue (Poosti et al., 2015; Stribos et al., 2016a,b). Murine
PCKS (mPCKS) are a promising model of renal fibrosis
pathophysiology as well as an easy drug-discovery tool having
several advantages compared to human PCKS such as tissue
availability, use of knockout models and identical genetic
Abbreviations: α-SMA, alpha-smooth muscle actin; ANOVA, One-way analysis
of variance; CKD, Chronic kidney disease; ECM, Extracellular matrix; ESRD, End-
stage renal disease; HSP47, Heat-shock protein 47; mPCKS, Murine precision-cut
kidney slices; PAS, Periodic Acid Schiff; PCKS, Precision-cut kidney slices; PSR,
Picrosirius Red; qPCR, Quantitative real-time polymerase chain reaction; SEM,
Standard error of the mean; siRNA, Small interfering RNA; TGF-β, Transforming-
growth factor beta; UW solution, University of Wisconsin cold storage solution.
background. Moreover, the use of PCKS contributes to the
reduction, refinement and replacement (“3Rs” principles) of
animal studies. In this study, we extensively characterized
the phenotype of mPCKS during extended culture (up to




LY2109761, a TGF-β receptor type I/II (TβRI/II) dual inhibitor,
was purchased from Selleck Chemicals, Munich, Germany. Stock
solutions were prepared in DMSO and stored at −20◦C. During
the experiments, stocks (5mM) were diluted in culture medium
with a final solvent concentration of ≤0.1%.
Animals
Tissue from male C57BL/6 mice (University Medical Center
Groningen, Groningen, the Netherlands) aged 8–15 weeks was
used for the experiments (n= 3 for long-term incubation studies
and n = 4–5 for studies with LY2109761). Animals were housed
under controlled conditions with a 12 h light/dark cycle and free
access to water and food (Harlan chow no. 2018, Horst, the
Netherlands). Organs were harvested via a terminal procedure
performed under isoflurane/O2 anesthesia. Kidneys were stored
in ice-cold University of Wisconsin (UW) organ preservation
solution until use. The animal experiments were evaluated and
approved by the Animal Ethics Committee of the University of
Groningen (DEC 6416AA-001).
Murine Precision-Cut Kidney Slices
Murine PCKS were prepared as described in detail by Poosti
et al. (2015). In short, murine kidneys were prepared by
removing adipose tissue and slices were made in ice-cold Krebs-
Henseleit buffer supplemented with 25mM D-glucose (Merck,
Darmstadt, Germany), 25mMNaHCO3 (Merck), 10mMHEPES
(MP Biomedicals, Aurora, OH, USA), and saturated with
carbogen (95% O2, 5% CO2) using a Krumdieck tissue slicer
(Figure 1). The obtained slices were 4.5mm in diameter and
had a wet weight of 4–6mg, corresponding to an estimated
thickness of 250–300µm. Slices were incubated, up to 96 h,
in Williams’ Medium E with GlutaMAX (Life Technologies,
Carlsbad) supplemented with 10µg/mL ciprofloxacin and 2.7
g/L D-(+)-Glucose solution (Sigma-Aldrich, Saint Louis) at 37◦C
in an 80% O2 and 5% CO2 atmosphere while gently shaken.
Medium was refreshed every 24 h. Murine PCKS were also
treated for 48 h with 2.5µM LY2109761, a TGF-β receptor
inhibitor. After incubation, mPCKS were snap-frozen in liquid
nitrogen and stored at−80◦C until use.
Viability of mPCKS
Viability of mPCKS was determined by measuring ATP content
(Roche diagnostics, Mannheim, Germany) and corrected for the
total protein content of the sample, which was estimated via
the Lowry assay (Bio Rad, Veenendaal, the Netherlands), as
described previously (Westra et al., 2013).
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FIGURE 1 | Workflow preparation of mPCKS. (A) Murine kidneys are prepared by removing the adipose tissue. (B) The entire kidney is placed in the core holder. (C)
Murine PCKS (250–300µm in thickness) are prepared with the Krumdieck slicer and subsequently kept in ice-cold University of Wisconsin (UW) solution. (D) Slices
are incubated in optimized medium at 37◦C and 80% O2, 5% CO2 in a gently shaking incubator. Adapted from Stribos et al. (2016b); used with permission from
Elsevier. PCKS, precision-cut kidney slices.
TABLE 1 | Primers and antibodies.














Antibody for Western Blot Collagen type 1 Primary: Rabbit anti-collagen type 1 (1:2,000; Rockland Immunochemicals, Limerick, USA)
Secondary: Goat anti-rabbit HRP (1:2,000, Dako, Santa Clara, USA)
α-smooth muscle actin (α-SMA) Mouse anti-α-SMA clone 1A4 (1:5,000; Sigma-Aldrich, St. Louis, USA)
Secondary: Rat anti-mouse HRP (1:5,000, Dako)
Heat-shock protein (HSP47) Rabbit anti-HSP47 (1:2,000; ab109117 Abcam, Cambridge, USA)
Secondary: Goat anti-rabbit HRP (1:2,000, Dako)
Gene Expression
Total RNA was extracted from mPCKS with the RNeasy mini
kit (Qiagen, Venlo, the Netherlands) using aMini-Beadbeater for
homogenization, and RNA (1µg) was reverse transcribed using
the Reverse Transcription System (Promega). Subsequently,
mRNA expression was evaluated by quantitative real-time
polymerase chain reaction (qPCR) performed with a 7900HT
qPCR system (Applied Biosystems). Relative fold change was
calculated using the 2−1Ct method using Gapdh as reference
gene. The TaqMan Gene Expression assays (Thermo Fisher
Scientific, Waltham, USA) and SYBR Green primer (Sigma-
Aldrich) used are listed in Table 1.
Western Blot
Total protein was extracted from mPCKS with ice-cold lysis
buffer (30mM Tris, 150mM NaCl, 1mM EDTA, 0.054% Triton
X-100, 1mM Na3VO4, 10mM NaF, and 1% SDS) and samples
were homogenized (five cycles of 45 s Minibead-beating and
10min cooling on ice). After 45min of centrifugation at
16,000 x g, samples were denatured at 75◦C for 10min. A
total of 100 µg was separated via sodium dodecyl sulfate–
polyacrylamide gel electrophoresis using 10% gels (containing
2,2,2-trichloroethanol, Sigma-Aldrich, for total protein) and
blotted onto polyvinylidene fluoride membranes (Trans-Blot
Turbo Transfer System, Bio-Rad, Hercules, USA). Membranes
were blocked in 5% non-fat milk/TBST (Bio-Rad) and incubated
with the primary antibody (Table 1) overnight at 4◦C followed by
incubation with the corresponding secondary antibody for 1 h.
Proteins bands were visualized using the Clarity Western ECL
blotting substrate (Bio-Rad) and the ChemiDoc Touch Imaging
System (Bio-Rad). Protein expression was normalized using total
protein stains for immunoblot.
Morphology
To assess general morphology, Periodic acid-Schiff (PAS)
staining was performed on 2µm sections from formalin-fixed
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FIGURE 2 | General morphology and viability. (A) PAS staining of mPCKS during culture, magnification × 10; insets, magnification × 20, scale bar represents
100µm. (B) Viability measured by ATP content during incubation. (C) Slice diameter in cm during incubation. *p < 0.05, **p < 0.001. Data is expressed as mean
(±SEM), n = 3. PCKS, precision-cut kidney slices.
paraffin-embedded slices. In addition, Picrosirius Red (PSR)
staining was used to visualize total collagen levels. Murine PCKS
diameter was measured using ImageJ (National Institutes of
Health).
Statistics
Statistics were performed using GraphPad Prism 6.0 via one-
way analysis of variance (ANOVA) followed by Dunnett’s
multiple comparisons test or an unpaired, two-tailed Student’s
t-test as appropriate. The results are expressed as mean ±
standard error of the mean (SEM). Regarding the qPCR results,
statistics were performed using the 1Ct values, while the data
is presented as fold change (2−1Ct). Differences between groups
were considered to be statistically significant when p< 0.05.
RESULTS
Morphology and General Viability
Morphology of mPCKS was checked with PAS staining at 0, 3,
24, 48, 72, and 96 h of incubation (Figure 2A). As illustrated,
kidney slices remained viable up to 48 h of incubation after
which the proximal tubular brush border disappeared and most
tubular cells became anuclear. Therefore, future experiments
were limited to 48 h. Furthermore, the ATP content of the slices
increased at the start of culture, after which the levels remained
constant (Figure 2B). These results show that mPCKS remained
viable for at least 48 h of culturing. Additionally, the diameter of
mPCKS reduced during culture (Figure 2C), in accordance with
results obtained with human PCKS.
Early Inflammatory and Late Fibrotic
Response during Incubation
Next, we investigated changes in the gene expression of mPCKS
during culture, with a focus an inflammation and fibrogenesis.
Gene expression of Il1b, Il6, and Cxcl1 markedly increased after
3 h of incubation (Figure 3A). Both Il6 and Cxcl1 mRNA levels
peaked at 3 h (fold change of 8,715 and 529, respectively), after
which the expression levels decreased, although they remained
higher as compared to 0 h. The expression pattern of Il1b had
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FIGURE 3 | Expression of fibrosis and inflammatory markers during incubation of mPCKS. (A) mRNA expression of inflammation markers. (B) mRNA expression of
fibrosis markers. (C) Protein levels of collagen type 1, α-SMA, and HSP47 at baseline and 48 h with representative Western blot images. (D) Picrosirius red staining of
mPCKS visibly increased at 72 h compared to baseline expression (0 h). *p < 0.05, **p < 0.001, ***p < 0.001, ****p < 0.0001. Data is expressed as mean (±SEM), n
= 3–5. Il1b, interleukin 1 beta; Il6, interleukin 6; Cxcl1, C-X-C motif chemokine ligand 1; Col1a1, collagen type I alpha 1; Serpinh1, serine proteinase inhibitor clade H
(Heat Shock Protein 47) member 1; Fn1, fibronectin 1; Acta2, alpha 2 smooth muscle actin; Pai-1, Plasminogen activator inhibitor-1; α-SMA (alpha smooth muscle
actin); HSP47, heat-shock protein 47; kDa, kilodalton.
a nearly constant increase during incubation (118 times fold
induction at 48 h) compared to 0 h slices.
We also observed a culture-induced fibrotic response in
mPCKS whereby Fn1 and Serpinh1 (i.e., heat-shock protein
47, HSP47) are already upregulated after 24 h (respectively
4.5- and 4.0-fold change compared to 0 h), while after 72 h
all four markers of fibrosis (Col1a1, Fn1, Serpinh1, and
Acta2) are highly expressed (Figure 3B). Moreover, Pai-1
gene expression greatly increased at 3 h of incubation (70-
fold induction) and even further at 24 h of incubation (420-
fold induction) after which levels plateaued. This increase in
fibrosis markers was also observed on protein level by western
blot (Figure 3C). Collagen type 1 and HSP47 significantly
increased at 48 h compared to baseline expression (90 and 98%
increase, respectively). These results were further confirmed
via a Picrosirius Red staining, which revealed increased
collagen levels at 72 h of incubation compared to baseline
(Figure 3D).
Role of TGF-β Pathway during Incubation
of mPCKS
Subsequently, we studied whether the TGF-β pathway is involved
in the observed onset of fibrosis in mPCKS. To this end,
mPCKS were incubated for 48 h with LY2109761, a selective
TGF-β receptor type I/II inhibitor. Our results demonstrated
that slice viability, as measured by ATP content, was not
affected by LY2109761 (Figure 4A). Furthermore, treatment with
LY2109761 significantly reduced the gene expression of all tested
fibrosis markers (Col1a1, Acta2, Serpinh1, Fn1, and Pai-1) at
48 h, as compared to control (Figure 4B). The inhibitor had
the strongest impact on Col1a1 and Fn1, both genes encoding
for ECM proteins. Surprisingly, following treatment, Col1a1
mRNA levels were even lower than in slices at 0 h (1.0 ± 0.1
at 0 h, 6.3 ± 0.6 at 48 h control and 0.3 ± 0.05 at 48 h with
LY2109761). In addition, LY2109761 prevented the strong Pai-
1 mRNA induction observed in control slices (96% reduction
compared to 48 h control slices). Moreover, we were able to
demonstrate a clear decrease in HSP47 protein expression when
slices were treated with LY2109761, whilst collagen type 1 and
α-SMA expression were not affected (Figures 5A–C).
DISCUSSION
Translational models of renal fibrosis to develop efficacious
antifibrotic therapies are lacking (Stribos et al., 2016a;
Klinkhammer et al., 2017) and there is an urgent need to
close the gap between in vivo studies and clinical trials. PCKS
have been around for several decades for pharmacotoxicology
studies and recently this ex vivo model has been implemented
in the fibrosis research field (Poosti et al., 2015; Genovese
et al., 2016; Zhang et al., 2016). Strengths of this promising
technique are the preserved multicellular heterogeneity and
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FIGURE 4 | TGF-β receptor inhibition in mPCKS by LY2109761. (A) Viability of slices treated with LY2109761 compared to 48 h control. (B) Reduction of fibrosis
gene expression (Col1a1, Acta2, Serpinh1, Fn1) in slices treated with LY2109761 for 48 h. *p < 0.05, **p < 0.001, ***p < 0.001, ****p < 0.0001. Data is expressed as
mean (±SEM), n = 4–5. mPCKS, murine precision-cut kidney slices; Col1a1, collagen type I alpha 1; Serpinh1, serine proteinase inhibitor clade H (Heat Shock Protein
47) member 1; Fn1, fibronectin 1; Acta2, alpha 2 smooth muscle actin; Pai-1, Plasminogen activator inhibitor-1.
organ architecture, the possibility to perform translational
research using human PCKS and the potential to replace/reduce
animal experiments.
In the present study, we demonstrate two different
applications of mPCKS namely as an ex vivomodel to study renal
fibrogenesis and as a screening tool for antifibrotic therapies
such as TGF-β inhibitors. Poosti et al. were the first to use
mPCKS to test the efficacy of potential antifibrotic therapies
(Poosti et al., 2015). However, they did not fully characterize
the ongoing inflammatory/fibrotic processes that take place
during mPCKS culture, which is highly important to interpret
the results obtained with this model. Our results demonstrated
the spontaneous onset of fibrosis during mPCKS culture, as
reflected by an increased gene expression of Col1a1, Serpinh1,
Fn1, Acta2, and Pai-1. Moreover, the acquired fibrotic phenotype
was corroborated on a protein level. Additionally, fibrogenesis
was preceded by an early inflammatory response on mRNA level,
which, although decreasing after 24 h, remained high during
culture. This is most probably caused by cell injury due to the
slicing procedure as well as a stress response due to incubation
at 37◦C. Early inflammation, followed by the induction of
ECM proteins concurrent with (proximal) tubular atrophy is
an important characteristic of renal fibrosis (Farris and Colvin,
2012), which is nicely reflected in mPCKS. Therefore, mPCKS
are an ideal model to study renal fibrogenesis. Additionally,
preservation of Acta2 gene and α-SMA protein expression
during incubation suggests survival of α-SMA expressing
(myo)fibroblasts during culture. In contrast, Acta2 expression
in human PCKS first dramatically decreases after which levels
rise again (Stribos et al., 2016b) which might reflect species
differences in the fibrotic process. After having extensively
characterized the pathological processes in mPCKS, we studied
the involvement of the TGF-β pathway herein. To this end,
mPCKS were incubated with the TGF-β receptor I/II inhibitor
LY2109761 for 48 h. LY2109761 ismostly studied in the context of
cancer research, and it has been demonstrated that this inhibitor
has antiproliferative effects and increases tumor sensitivity
to treatment (Gao et al., 2015; Alsina-Sanchis et al., 2016).
Regarding fibrosis, it has been shown to reduce radiation- or
bleomycin-induced lung fibrosis (Flechsig et al., 2012; Zhu et al.,
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FIGURE 5 | Protein levels of Collagen type 1 alpha 1, HSP47 and α-SMA of PCKS at 0 h, 48 h and treated with LY2109761, a TGF-β receptor type I/II (TβRI/II) dual
inhibitor. (A) Representative Western blot images of Collagen type 1 alpha 1, HSP47, α-SMA and GAPDH. (B) Total protein stain with 2,2,2-trichloroethanol. (C)
Quantification of detected proteins, after correction for total protein content. *p < 0.05, **p < 0.001. Data is expressed as mean (±SEM), n = 4. α-SMA, alpha smooth
muscle actin; HSP47, heat-shock protein 47; kDa, kilodalton; LY, LY2109761.
FIGURE 6 | Future perspectives. PCKS, precision-cut kidney slices; ESRD, end-stage renal disease; UUO, unilateral ureteral obstruction.
2017). Our study confirmed the antifibrotic effect of LY2109761
as we observed a remarkable decrease in the expression of
fibrosis genes. Expression of Pai-1—a downstream signaling
molecule of the TGF-β1 pathway (Krag et al., 2005; Samarakoon
et al., 2013)—markedly increased during incubation and was
mitigated by LY2109761, indicating that TGF-β1 signaling is one
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the driving forces for fibrogenesis in mPCKS. Even on a protein
level, a significant decrease of HSP47 was observed compared to
control. HSP47 expression is closely linked to collagen formation
(Razzaque and Taguchi, 1997; Razzaque et al., 1998; Liu et al.,
2001; Xiao et al., 2012) and plays an important role in the correct
folding and assembly of procollagen molecules (Taguchi and
Razzaque, 2007). Additionally, involvement of the protein in
fibrotic lesions in the kidney has been established (Abe et al.,
2000; Ohba et al., 2005) and when targeted a reduction in renal
fibrosis is observed in a UUO animal model (Sunamoto et al.,
1998; Xia et al., 2008). Therefore, the observed decrease in HSP47
protein expression is a strong indicator of the antifibrotic efficacy
of LY2109761. Importantly, the LY2109761 concentration
(2.5µM) used in this study is low compared to studies in
dermal fibroblasts (10–20µM; Wang et al., 2015, 2016). In
conclusion, these studies demonstrate that the TGF-β pathway
plays a major role in the onset of fibrosis in mPCKS and indicate
that this pathway is an interesting therapeutic target for renal
fibrosis.
Limitations of the mPCKS model are the lack of circulating
inflammatory and bone-marrow-derived cells contributing to the
pathophysiology of renal fibrosis (Lin et al., 2009; Meng et al.,
2014), the absence of blood- and urine flow as well as missing
interorgan interactions. The latter might be circumvented by
co-incubating mPCKS with liver/heart/intestinal slices by using
microfluidic biochips (van Midwoud et al., 2010). Additionally,
the discrepancy between stable ATP levels, indicating active
glycolysis and cellular respiration, and the observed loss of
proximal tubular brush borders, reflecting tubular damage, needs
to be addressed in future studies to further improve the model.
This ex vivo model of PCKS is still in its infancy and offers
a vast array of applications (Figure 6). Firstly, one can vary the
renal tissue used. Instead of healthy kidneys, diseased renal tissue
can be opted for such as from UUO mice. In a similar fashion,
the culture of PCKS from human fibrotic tissue from non-
functioning renal allografts or ESRD native kidneys is currently
being developed in our lab. In the case of mPCKS, specific
genes can be studied by using knockout models. Otherwise,
siRNA treatment is an alternative option for murine as well as
human PCKS, which is currently being studied in our group.
Additionally, study of renal disease in PCKS is certainly not
limited to fibrosis as this model is also highly suitable to study
acute kidney injury.
In conclusion, we present a characterized model of mPCKS
to study renal disease (i.e., fibrosis) and show the pivotal role of
the TGF-β pathway in the spontaneous onset of fibrosis during
incubation. Still, PCKS technology is continuously evolving as a
translational model and promises to be an innovative technique
that can be used as replacement and reduction for animal
experiments.
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